For example, ANXA3 overexpression was found to correlate with enhanced drug resistance in ovarian cancer, promote the development of colorectal adenocarcinoma and pancreatic carcinoma, and facilitate metastasis of lung adenocarcinoma and hepatocarcinoma. Here, ANXA3 is linked to ovarian carcinoma.